Baker Bros. Advisors LP Design Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,695,294 shares of DSGN stock, worth $9.17 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,695,294
Previous 1,662,120
2.0%
Holding current value
$9.17 Million
Previous $6.7 Million
15.21%
% of portfolio
0.08%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding DSGN
# of Institutions
100Shares Held
31.9MCall Options Held
1.1KPut Options Held
21.3K-
Sr One Capital Management, LP6.53MShares$35.3 Million9.6% of portfolio
-
Logos Global Management LP San Francisco, CA5.03MShares$27.2 Million1.58% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$12.5 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$8.01 Million0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$7.02 Million0.0% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $302M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...